VRPX

Virpax Pharmaceuticals, Inc. Common Stock
VRPX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

VRPX was delisted on the 3rd of April, 2025.

Back to rankings

1 hedge funds and large institutions have $91 invested in Virpax Pharmaceuticals, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
1
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$88

Top Sellers

1
-$26.5K
2
-$5.88K
3
-$2.4K
4
SS
SBI Securities
Japan
-$130
5
Bank of America
Bank of America
North Carolina
-$6
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
1
Osaic Holdings
Arizona
$91
Millennium Management
2
Millennium Management
New York
–
TRCT
3
Tower Research Capital (TRC)
New York
–
UBS Group
4
UBS Group
Switzerland
–
SS
5
SBI Securities
Japan
–
Bank of America
6
Bank of America
North Carolina
–
VWM
7
Vermillion Wealth Management
Minnesota
–